Drug-induced splenic enlargement

Expert Opinion on Drug Safety

Volumn 6, Issue 2, 2007, Pages 199-206

  Petroianu, Andy ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Haemolytic anaemia; Liver disturbances; Side effects; Splenic enlargement; Splenomegaly

Indexed keywords

ACEPROMAZINE; AMITRIPTYLINE; ANTIHISTAMINIC AGENT; AZATHIOPRINE; BARBITURIC ACID DERIVATIVE; BENZO[A]PYRENE; BUTORPHANOL; CEPHALOSPORIN; CYPROHEPTADINE; DIAZEPAM; FLUDARABINE; IBUPROFEN; KETAMINE; LEVODOPA; MEDETOMIDINE; MEFENAMIC ACID; METHOTREXATE; METHYLDOPA; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLIN DERIVATIVE; PHENACETIN; PIROXICAM; QUINIDINE; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RIFAMPICIN; SEROTONIN ANTAGONIST; SULINDAC; THIOPENTAL; UNINDEXED DRUG;

ACUTE HEPATITIS; ANAMNESIS; CELL PROLIFERATION; CHOLESTASIS; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EXPOSURE; DRUG MEGADOSE; HEMATOPOIETIC SYSTEM; HEMOLYSIS; HEMOLYTIC ANEMIA; HUMAN; IMMUNOLOGY; LEUKOCYTOSIS; LIVER DYSFUNCTION; LIVER TOXICITY; LOW DRUG DOSE; NEUTROPENIA; NONHUMAN; PORTAL VEIN OBSTRUCTION; REVIEW; SPLEEN CELL; SPLEEN RUPTURE; SPLEEN TRANSPLANTATION; SPLEEN WEIGHT; SPLENECTOMY; SPLENOMEGALY; VENOUS CONGESTION;

ANIMALS; HUMANS; PHARMACEUTICAL PREPARATIONS; SPLEEN; SPLENOMEGALY;

EID: 33847694758     PISSN: 14740338     EISSN: None     Source Type: Journal    
DOI: 10.1517/14740338.6.2.199     Document Type: Review

References (56)

1. PETROIANU A, BARBOSA AJA: Quantitative studies on the macrophage phagocytosis in whole spleen and in the remnant of subtotal splenectomy. Med. Sci. Res. (1991) 19:373-375.
2. PETROIANU A, OLIVEIRA AE, ALBERTI LR: Hypersplenism in schistosomatic portal hypertension. Arch. Med. Res. (2005) 36:496-501.
3. PETROIANU A: Treatment of portal hypertension by subtotal splenectomy and central splenorenal shunt. Postgrad. Med. J. (1988) 64:38-41.
4. PETROIANU A: Subtotal splenectomy and portal-variceal disconnection in the treatment of portal hypertension. Can. J. Surg. (1993) 36:251-254.
5. PETROIANU A: Subtotal splenectomy in Gaucher's disease. Eur. J. Surg. (1996) 162:511-513.
6. PETROIANU A: Subtotal splenectomy for treatment of patients with myelofibrosis and myeloid metaplasia. Int. Surg. (1996) 81:177-179.
7. PETROIANU A, VIDIGAL FM, COSTA VC, OLIVEIRA SC: Spelenic autotransplantation in Gaucher's disease. Dig. Surg (2000) 17:181-183.
8. PETROIANU A: Subtotal splenectomy for treatment of retarded growth and sexual development associated with splenomegaly. Minerva Chir. (2002) 57:428-429.
9. PETROIANU A: Subtotal splenectomy for the treatment of chronic lymphocytic leukemia. Ann. Hematol. (2003) 82:708-709.
10. PETROIANU A, PETROIANU LPG: Splenic autotransplantation for treatment of portal hypertension. J. Can. Chir. (2005) 48:382-386.
11. BECKER PS, WAGLEW M, MATOUS S et al.: Spontaneous splenic rupture following administration of granulocyte colony-stimulating factor. Biol. Blood Marrow Transplant. (1997) 3:45-49.
12. CALDERWOOD S, KILPATRICK L, DOUGLAS SD et al.: Recombinant human granulocyte colony-stimulating factor therapy for patients with neutropenia and neutrophil dysfunction secondary to glycogen storage disease type 1b. Blood (2001) 97:376-382.
13. KRAKOWSKI M, ABDELMALIK R, MOCNICK L, KRAHL T, SARVETNICK N: granulocyte macrophage-colony stimulating factor recruits immune cells to the pancreas and delay STZ-induced diabetes. J. Pathol. (2002) 196:103-112.
14. NAKAYAMA T, KUDO H, SUZUKI S, SASSA S, MANO Y, SAKAMOTO S: Splenomegaly induced by recombinant human granulocyte-colony stimulating factor in rat. Life Sci. (2001) 69:1521-1529.
15. PICARDI M, DEROSA G, SELLERI C et al.: Spleen enlargement following recombinant human granulocyte colony-stimulating factor administration for peripheral blood stem cell mobilization. Haematologica (2003) 88:794-800.
16. PLATZBECKER U, KREX GP, BORNHÄUSER M et al.: Spleen enlargement in healthy donors during G-CSF mobilization of PBPCs. Transfusion (2001) 41:184-189.
17. STRONCEK D, SHAWKER T, FOLLMANN D, LEITMAN SF: G-CSF- induced spleen size changes in peripheral blood progenitor cell donors. Transfusion (2003) 43:609-613.
18. TABILIO A: Spontaneous rupture of spleen during peripheral blood stem-cell mobilisatlon in a healthy donor. Lancet (1999) 353:555.
19. VISSER J, HILLEBRENDS JL, ROZING J: No evidence that rifampicin has glucocorticoid-like immunosuppressive properties leading to suppression of rat-splenocyte proliferation in vitro. J. Antimicrob. Chemother. (2001) 47:894-895.
20. HEJMANCIK MR, RYAN MJ, TOFT JD, PERSING RL, KURTZ PJ, CHHABRA RS: Hematological effects in F344 rats and B6C3F1 mice during the 13-week gavage toxicity study of methylene blue trihydrate. Toxicol. Sci. (2002) 65:126-134.
21. BOOKER CD, WHITE JR KL: Benzo[a]pyrene-induced anemia and splenomegaly in NZB/WF1 MICE. Food Chem. Toxicol. (2005) 43:1423-1431.
22. CICCOLI L, FERRALI M, ROSSI V, SIGNORINI C, ALESSANDRI C, COMPORTI M: Hemolytic drugs aniline and dapsone induce iron release in erythrocytes and increase the free iron pool in spleen and liver. Toxicol. Lett. (1999) 110:57-66.
23. O'BRIEN RT, KENNETH R, WALLER KR, OSGOOD TL: Sonographc features of drug-induced splenic congestion. Vet. Radiol. Ultrasound (2004) 45:225-227.
24. WILSON DV, EVANS AT, MULLINEAUX DR: The effect of four anesthetic protocols on splenic size in dogs. Vet. Anaesth. Analg. (2004) 31:102-108.
25. ROUDEBUSH RE, BRYANT HU: Pharmacologic manipulation of graft versus host induced splenomegaly. Agents Actions (1992) 35:260-267.
26. KAUFMAN MJ, SIEGEL AJ, MENDELSON JH et al.: Cocaine administration induces human splenic constriction and altered hematologic parameters. J. Appl. Physiol. (1998) 85:1877-1883.
27. LOPEZ MC, CHEN GJ, COLOMBO LL et al.: Spleen and thymus cell subset modified by long-term morphine administration and murine AIDS-II. Int. J. Immunopharmacol. (1993) 15:909-918.
28. ASHA S: Hemolytic anemia. Indian J. Med. Sci. (2004) 58:400-404.
29. DRISCOLL MS, KNODEL LC: Induction of hemolytic anemia by nonsteroidal antiinflammatory drugs. Drug Intell. Clin. Pharm. (1986) 20:925-934.
30. GARRATTY G, PETZ LD: Drug-induced immune hemolytic anemia. Am. J. Med. (1975) 58:398-407.
31. ARNDT PA, GARRATTY G: The changing spectrum of drug-induced immune hemolytic anemia. Semin. Hematol. (2005) 42:137-144.
32. WRIGHT MS: Drug-induced hemolytic anemias. Clin. Lab. Sci. (1999) 12:115-118.
33. SCHRIER SL: Hemoglobonopathies and hemolytic anemias. ACP Medicine Online (2002): 1-14.
34. HUANG Y, ANANTHAKRISHNAN T, EID JE: Hydroxyurea-induced splenic rregrowth in an adult patient with severe hemoglobin SC disease. Am. J. Hematol. (2003) 74:125-126.
35. HAMADA T, TANIMOTO A, ARIMJA N et al.: Pathological study of splenomegaly associated with cadmium-induced anemia in rats. J. UOEH (1998) 20:11-19.
36. WAUTIER JL, ROUGER P: Anémie hémolytique induite par les médicaments. Transfus. Clin. Biol. (2001) 8:377-380.
37. FARRELL GC: Drug-induced hepatic injury. J. Gastroenterol. Hepatol. (1997) 12:S242-S250.
38. ALTINTAS E, OGUZ D, KACAR S, OZDERIN Y, SEZGIN O, ZENGIN NI: Drug-induced hepatitis, drug-induced autoimmunity or classical autoimmune hepatitis. Turk J. Gastroenterol. (2004) 15:123-125.
39. HARTLEB M, BIERNAT L, KOCHEL A: Drug-induced liver damage. Med. Sci. Monit. (2002) 8:CR292-CR296.
40. LEBREC D, BENHAMOU JP: Noncirhotic intrahepatic portal hyeprtension. Semin. Liver Dis. (1986) 6:332-340.
41. LIU ZX, KAPTOWITZ N: Immune-mediated drug-induced liver disease. Clin. Liver Dis. (2002) 6:755-774.
42. ZIMMERMAN HJ: Drug-induced chronic hepatic disease. Med. Clin. North Am. (1979) 63:567-582.
43. PAI VB, KORANYI K, NAHATA MC: Acute hepatitis and bleeding possibility induced by zidovudine and ritonavir in an infant with HIV infecction. Pharmacotherapy (2000) 20:1135-1140.
44. ROSIN AJ, VANDIJK YM, GRAFSTEIN I, HERBERT J: Hepatosplenomegaly as a manifestation of quinidine hypersensitivity. Age. Ageing (1980) 9:253-256.
45. SIPE WEB, SU M, POSSELT A, KIM GE, QUIROS JA, ROSENTHAL P: Propylthiouracil-associated liver failure presenting as probable autoimmune hepatitis in a child with Graves' disease. Pediatr. Transplant. (2006) 10:1-3.
46. BROXSON EH, DOLE M, WONG R, LAYA BF, STORK L: Portal hypertension develops in a subset of children with standard risk acute lymphoblastic leukemia treated with thioguanine during maintenance therapy. Pediatr. Blood Cancer (2005) 44:226-231.
47. BORINI P, GUIMARÃES REC, BORINI SB: Possible hepatotoxicity of chronic marijuana usage. São Paulo Med. J. (2004) 122:110-116.
48. PETROIANU A, RESENDE V, SILVA RG: Late follow-up of patients submitted to subtotal splenectomy. Int. J. Surg (2006) 4:152-158.
49. PETROIANU A, PETROIANU S: Anatomy of splenogastric vessels in patients with schistosomal portal hypertension. Clin. Anat. (1994) 7:80-83.
50. PETROIANU A, BARBOSA AA, SIMAL CJR: Assessment of phagocytic function in remnants of subtotal splenectomy and in autologous spleen implantation. Med. Sci. Res. (1993) 21:715-717.
51. RESENDE V, PETROIANU A, JUNIOR WC: Autotransplantation for treatment of severe splenic lesions. Emerg. Radiol. (2002) 9:208-212.
52. RESENDE V, PETROIANU A: Functions of the splenic remnant after subtotal splenectomy for treatment of severe splenic injuries. Am. J. Surg. (2003) 185:311-315.
53. PETROIANU A, NETO RB: Laparoscopic subtotal splenectomy. Minerva Chir. (2004) 59:501-505.
54. PETROIANU A, ANDRADE MAC, NETO RB: Laparoscopic subtotal splenectomy. Aust. NZ J. Surg. (2007) (In Press).
55. PETROIANU A, ANDRADE MAC, NETO RB: Laparoscopic splenic autotransplantation. Surg. Laparosc. Endosc. Percut. Tech. (2006) 16(4):259-262.
56. PETROIANU A, SILVA RG, SIMAL CJ, CARVALHO DG, SILVA RAP: Late postoperative follow-up of patients submitted to subtotal splenectomy. Am. Surg. (1997) 63:735-740.